Combined penetrating keratoplasty and trabeculectomy with mitomycin C

Ophthalmology. 1999 Feb;106(2):396-400. doi: 10.1016/S0161-6420(99)90081-7.

Abstract

Objective: To evaluate corneal graft survival and intraocular pressure control in eyes that have undergone combined penetrating keratoplasty and trabeculectomy with mitomycin C (MMC).

Design: Retrospective noncomparative case series.

Intervention: Penetrating keratoplasty combined with trabeculectomy with MMC and other surgical procedures.

Participants: Twenty-four eyes of 22 patients undergoing combined penetrating keratoplasty and trabeculectomy with mitomycin C.

Main outcome measures: Corneal graft clarity and intraocular pressure control.

Results: The cumulative probability of corneal graft survival was 85% at 1 year and 60% at 2 years. The cumulative probability of adequate pressure control was 67% at 3 months, 55% at 12 months, and 50% at 24 months. The incidence of bleb failure was higher in cases involving additional concomitant procedures, such as anterior vitrectomy, lens implantation or exchange, and drainage tube implantation.

Conclusions: Combined penetrating keratoplasty and trabeculectomy with mitomycin C is associated with good corneal graft survival but also a risk of early failure of intraocular pressure control. Other concomitant procedures during the combined penetrating keratoplasty/trabeculectomy may increase the risk of early bleb failure.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Corneal Diseases / surgery*
  • Female
  • Glaucoma / drug therapy
  • Glaucoma / surgery*
  • Graft Survival / physiology
  • Humans
  • Intraocular Pressure / physiology
  • Keratoplasty, Penetrating*
  • Male
  • Middle Aged
  • Mitomycin / therapeutic use*
  • Retrospective Studies
  • Trabeculectomy*
  • Treatment Outcome
  • Visual Acuity

Substances

  • Mitomycin